CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CVS - US1266501006 - Common Stock
65.4 EUR
-4.6 (-6.57%)
Taking everything into account, 1CVS scores 4 out of 10 in our fundamental rating. 1CVS was compared to 29 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1CVS was profitable.
1CVS had a positive operating cash flow in the past year.
In the past 5 years 1CVS has always been profitable.
In the past 5 years 1CVS always reported a positive cash flow from operatings.
1.2 Ratios
1CVS's Return On Assets of 0.18% is on the low side compared to the rest of the industry. 1CVS is outperformed by 67.74% of its industry peers.
1CVS has a worse Return On Equity (0.64%) than 70.97% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.90%, 1CVS is in line with its industry, outperforming 51.61% of the companies in the same industry.
1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 6.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROIC | 4.9% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
With a Profit Margin value of 0.12%, 1CVS is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of 1CVS has declined.
1CVS has a worse Operating Margin (2.73%) than 67.74% of its industry peers.
1CVS's Operating Margin has declined in the last couple of years.
1CVS's Gross Margin of 13.88% is on the low side compared to the rest of the industry. 1CVS is outperformed by 64.52% of its industry peers.
1CVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CVS is destroying value.
The number of shares outstanding for 1CVS has been reduced compared to 1 year ago.
Compared to 5 years ago, 1CVS has less shares outstanding
The debt/assets ratio for 1CVS is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.25 indicates that 1CVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
1CVS has a Altman-Z score (2.25) which is comparable to the rest of the industry.
1CVS has a debt to FCF ratio of 10.46. This is a negative value and a sign of low solvency as 1CVS would need 10.46 years to pay back of all of its debts.
1CVS has a Debt to FCF ratio (10.46) which is in line with its industry peers.
A Debt/Equity ratio of 0.85 indicates that 1CVS is somewhat dependend on debt financing.
The Debt to Equity ratio of 1CVS (0.85) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.62
WACC7.92%
2.3 Liquidity
A Current Ratio of 0.83 indicates that 1CVS may have some problems paying its short term obligations.
1CVS has a Current ratio (0.83) which is in line with its industry peers.
A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
With a Quick ratio value of 0.63, 1CVS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
1CVS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.87%.
1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.20% yearly.
1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.82%.
1CVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.74% yearly.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
3.2 Future
The Earnings Per Share is expected to grow by 12.34% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.18, which indicates a very decent valuation of 1CVS.
1CVS's Price/Earnings ratio is rather cheap when compared to the industry. 1CVS is cheaper than 83.87% of the companies in the same industry.
1CVS is valuated cheaply when we compare the Price/Earnings ratio to 26.87, which is the current average of the S&P500 Index.
1CVS is valuated reasonably with a Price/Forward Earnings ratio of 10.61.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 80.65% of the companies listed in the same industry.
1CVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 10.61 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as 1CVS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.45 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CVS's earnings are expected to grow with 14.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y15.41%
EPS Next 3Y14.66%
5. Dividend
5.1 Amount
1CVS has a Yearly Dividend Yield of 3.42%.
1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.45. 1CVS pays more dividend than 90.32% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, 1CVS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
5.2 History
The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1CVS pays out 722.81% of its income as dividend. This is not a sustainable payout ratio.
1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
BIT:1CVS (12/8/2025, 7:00:00 PM)
65.4
-4.6 (-6.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.68%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap83.02B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80.61
Price Target77.36 (18.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
Yearly Dividend2.26
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)11.07%
PT rev (3m)10.58%
EPS NQ rev (1m)4.24%
EPS NQ rev (3m)5.66%
EPS NY rev (1m)3.6%
EPS NY rev (3m)3.85%
Revenue NQ rev (1m)2.19%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)1.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 10.61 | ||
| P/S | 0.25 | ||
| P/FCF | 15.45 | ||
| P/OCF | 10.67 | ||
| P/B | 1.33 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.85
EY8.94%
EPS(NY)6.16
Fwd EY9.42%
FCF(TTM)4.23
FCFY6.47%
OCF(TTM)6.13
OCFY9.37%
SpS265.06
BVpS49.05
TBVpS-25.92
PEG (NY)0.49
PEG (5Y)N/A
Graham Number80.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROCE | 6.61% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.26% | ||
| ROICexgc | 19.51% | ||
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% | ||
| FCFM | 1.6% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.71% | ||
| Interest Coverage | -3.53 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 1341.79% | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.25 |
F-Score6
WACC7.92%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.12%
EBIT Next 3Y19.3%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%
CVS HEALTH CORP / 1CVS.MI FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1CVS.MI.
What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for CVS HEALTH CORP?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.
How financially healthy is CVS HEALTH CORP?
The financial health rating of CVS HEALTH CORP (1CVS.MI) is 2 / 10.
Is the dividend of CVS HEALTH CORP sustainable?
The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 722.81%.